Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · IEX Real-Time Price · USD
4.550
+0.070 (1.56%)
At close: May 17, 2024, 4:00 PM
4.650
+0.100 (2.20%)
After-hours: May 17, 2024, 4:05 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $14.94 million as of May 17, 2024. Its market cap has decreased by -24.54% in one year.
Market Cap
14.94M
Enterprise Value
12.20M
1-Year Change
-24.54%
Ranking
Category
Stock Price
$4.55
Market Cap Chart
Since November 5, 2015, Edesa Biotech's market cap has decreased from $74.90M to $14.94M, a decrease of -80.05%. That is a compound annual growth rate of -17.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 16, 2024 | 14.50M | - |
May 15, 2024 | 14.50M | -0.68% |
May 14, 2024 | 14.60M | 2.10% |
May 13, 2024 | 14.30M | -3.38% |
May 10, 2024 | 14.80M | 3.50% |
May 9, 2024 | 14.30M | -0.69% |
May 8, 2024 | 14.40M | 0.70% |
May 7, 2024 | 14.30M | 0.70% |
May 6, 2024 | 14.20M | -3.40% |
May 3, 2024 | 14.70M | 2.08% |
May 2, 2024 | 14.40M | 2.13% |
May 1, 2024 | 14.10M | - |
Apr 30, 2024 | 14.10M | 1.44% |
Apr 29, 2024 | 13.90M | -0.71% |
Apr 26, 2024 | 14.00M | -1.41% |
Apr 25, 2024 | 14.20M | 3.65% |
Apr 24, 2024 | 13.70M | -3.52% |
Apr 23, 2024 | 14.20M | 2.16% |
Apr 22, 2024 | 13.90M | -1.42% |
Apr 19, 2024 | 14.10M | 2.17% |
Apr 18, 2024 | 13.80M | -1.43% |
Apr 17, 2024 | 14.00M | 1.45% |
Apr 16, 2024 | 13.80M | 4.55% |
Apr 15, 2024 | 13.20M | -7.04% |
Apr 12, 2024 | 14.20M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Talis Biomedical | 15.89M |
Tonix Pharmaceuticals Holding | 15.43M |
Psychemedics | 15.38M |
Akso Health Group | 15.17M |
RedHill Biopharma | 14.53M |
Star Equity Holdings | 14.23M |
Mainz Biomed B.V. | 14.12M |
Pieris Pharmaceuticals | 14.02M |